The RANK/RANKL signalling, as discussed before, induces an osteolytic and immunosuppressive PMN in bone via the induction of osteoclastogenesis [66] and Treg expansion [46], which suggests targeting RANK/RANKL will potentially be effective in preventing PMN formation and bone metastasis by tumours. The gene discussed is TNFSF11; the disease is neoplasm.